ACT-HIB

Ingredient : Haemophilus influenzae type B polysaccharide (polyribosyl-ribitol-phosphate or PRP)

Company Name : Sanofi India Ltd

Diseases Type : H-INFLEUNZA B

Uses : Act-HIB is a vaccine that protects against infections caused by Haemophilus influenzae type B (Hib). Hib is a bacterium that can lead to serious diseases, especially in young children, such as meningitis, pneumonia, and epiglottitis. Key Details: Active Ingredient: The vaccine contains purified Haemophilus influenzae type B polysaccharide (polyribosyl-ribitol-phosphate or PRP) conjugated to tetanus toxoid protein. This conjugation enhances the immune response, making the vaccine more effective in young children. Formulation: Act-HIB is usually provided as a lyophilized powder (freeze-dried) that must be reconstituted with a saline solution or another suitable diluent before administration.

Side Effects : Common side effects can include: Local reactions at the injection site (e.g., redness, swelling) Fever Irritability Loss of appetite

Act-HIB is an important vaccine in the prevention of serious diseases caused by Haemophilus influenzae type B in children. It is a critical part of the routine immunization schedule in many countries. As with all vaccines, consultation with a healthcare provider is recommended to understand the full benefits and any potential risks.